SCHEMBL2315833

SCHEMBL2315833

COc1ccc2c(c1)OCC(C)(C)C=C2/C=C/C(C)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
HTR2B P41595 2/20 0.37
SIGMAR1 Q99720 2/20 0.37
HTR7 P34969 1/20 0.37
TMEM97 Q5BJF2 1/20 0.37
CYP3A4 P08684 6/20 0.36
ALDH1A1 P00352 6/20 0.36
MAPT P10636 5/20 0.36
KDM4E B2RXH2 5/20 0.36
HPGD P15428 3/20 0.36
HSD17B10 Q99714 3/20 0.36
MAPK1 P28482 3/20 0.36
LMNA P02545 2/20 0.36
CYP19A1 P11511 3/20 0.36
PGR P06401 1/20 0.36
HTR1A P08908 1/20 0.36
MEN1 O00255 2/20 0.35
ALOX15 P16050 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2315836 1.00 ESR1 (0.38) ESR1ESR2HTR2BSIGMAR1HTR7
SCHEMBL2317267 0.91 RAB9A (0.38) HTR2BSIGMAR1HTR7TMEM97ALDH1A1
SCHEMBL2317270 0.91 RAB9A (0.38) HTR2BSIGMAR1HTR7TMEM97ALDH1A1
SCHEMBL3609449 0.88 RXRA (0.39) ESR1ESR2HTR2BSIGMAR1HTR7
SCHEMBL3609445 0.88 RXRA (0.39) ESR1ESR2HTR2BSIGMAR1HTR7
SCHEMBL2314373 0.86 HTR1A (0.37) ESR1ESR2HTR2BSIGMAR1CYP3A4
SCHEMBL2314377 0.86 HTR1A (0.37) ESR1ESR2HTR2BSIGMAR1CYP3A4
SCHEMBL3646383 0.84 MAPT (0.36) ESR1ESR2HTR2BSIGMAR1CYP3A4
SCHEMBL3646386 0.84 MAPT (0.36) ESR1ESR2HTR2BSIGMAR1CYP3A4
SCHEMBL2317450 0.83 MAPK1 (0.33) ESR1ESR2MAPTKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1609786-B1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids MERCK SANTE SAS (FR) 2011-08-03 EP claimed
EP-1758876-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GmbH (DE) 2007-03-07 EP claimed
WO-2006002721-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GMBH (DE) 2006-01-12 WO claimed
EP-1609786-A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids Merck Sante (FR) 2005-12-28 EP claimed
EP-1609786-B1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids MERCK SANTE SAS (FR) 2011-08-03 EP disclosed
EP-1758876-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GmbH (DE) 2007-03-07 EP disclosed
WO-2006002721-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GMBH (DE) 2006-01-12 WO disclosed
EP-1609786-A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids Merck Sante (FR) 2005-12-28 EP disclosed